INJECTABL-II trial: Dose finding, efficacy and immunological response of a novel immuno-adjuvant (IP-001) following microwave ablation or irreversible electroporation for colorectal liver metastases.

2023-504572-25-00 Phase I and Phase II (Integrated) - Other Ongoing, recruiting

Start 25 Jun 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 3 sites

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - Other
Status Ongoing, recruiting
Participants planned 119
Countries 1
Sites 3

Colorectal liver metastases

Key facts

Sponsor
Amsterdam UMC
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02], Analytical,Diagnostic,Therapeutic Techniques and Equipment [E]-Surgical Procedures, Operative [E04]
Trial duration
25 Jun 2024 → ongoing
Decision date (initial)
2024-05-13
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2023-504572-25-00
WHO UTN
U1111-1290-1350
ClinicalTrials.gov
NCT06630624

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Colorectal liver metastases

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Amsterdam UMC

Sponsor organisation
Amsterdam UMC
Address
De Boelelaan 1117
City
Amsterdam
Postcode
1081 HV
Country
Netherlands

Scientific contact point

Organisation
Amsterdam UMC
Contact name
A.J.M. van den Broek

Public contact point

Organisation
Amsterdam UMC
Contact name
Amsterdam UMC - Location VUmc

Locations

1 EU/EEA country · 3 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 119 3
Rest of world 0

Investigational sites

Netherlands

3 sites · Ongoing, recruiting
Amsterdam UMC
Radiology and Nuclear Medicine, De Boelelaan 1117, 1081 HV, Amsterdam
Noordwest Ziekenhuisgroep Stichting
Interventieradioloog, Radiologie, Wilhelminalaan 12, 1815 JD, Alkmaar
Universitair Medisch Centrum Utrecht
Department of Radiology - Imaging and Cancer Division, Heidelberglaan 100, 3584 CX, Utrecht

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2024-06-25 2024-07-12

Application history

7 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-01-24 Netherlands Acceptable
2024-05-06
2024-05-13
2 NON SUBSTANTIAL MODIFICATION NSM-3 2024-07-26 Netherlands Acceptable
2024-05-06
2024-07-26
3 SUBSTANTIAL MODIFICATION SM-4 2024-09-23 Netherlands Acceptable
2024-10-24
2024-10-25
4 SUBSTANTIAL MODIFICATION SM-5 2024-12-11 Netherlands Acceptable
2025-03-05
2025-03-05
5 SUBSTANTIAL MODIFICATION SM-6 2025-05-02 Netherlands Acceptable
2025-06-10
2025-06-11
6 SUBSTANTIAL MODIFICATION SM-7 2025-10-22 Netherlands Acceptable
2025-12-16
2026-01-07
7 SUBSTANTIAL MODIFICATION SM-8 2026-04-22 Netherlands Acceptable
2026-05-20
2026-05-28